Show simple item record

dc.contributor.authorDamm, Oliver
dc.contributor.authorHorn, Johannes
dc.contributor.authorMikolajczyk, Rafael T
dc.contributor.authorKretzschmar, Mirjam E E
dc.contributor.authorKaufmann, Andreas M
dc.contributor.authorDeleré, Yvonne
dc.contributor.authorUltsch, Bernhard
dc.contributor.authorWichmann, Ole
dc.contributor.authorKrämer, Alexander
dc.contributor.authorGreiner, Wolfgang
dc.date.accessioned2018-01-09T13:53:41Z
dc.date.available2018-01-09T13:53:41Z
dc.date.issued2017
dc.identifier.citationCost-effectiveness of human papillomavirus vaccination in Germany. 2017, 15:18 Cost Eff Resour Allocen
dc.identifier.issn1478-7547
dc.identifier.pmid28878573
dc.identifier.doi10.1186/s12962-017-0080-9
dc.identifier.urihttp://hdl.handle.net/10029/621101
dc.description.abstractThe aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.
dc.language.isoenen
dc.rightsArchived with thanks to Cost effectiveness and resource allocation : C/Een
dc.titleCost-effectiveness of human papillomavirus vaccination in Germany.en
dc.typeArticleen
dc.identifier.journalCost Eff Resour Alloc 2017, 15(1):18en
refterms.dateFOA2018-12-18T14:02:19Z
html.description.abstractThe aim of this study was to assess the cost-effectiveness of human papillomavirus (HPV) vaccination in addition to the current cervical cancer screening programme in Germany using a dynamic transmission model.


Files in this item

Thumbnail
Name:
s12962-017-0080-9.pdf
Size:
1002.Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record